Excessive esophageal toxicity in patients with locally advanced non-small cell lung cancer treated with concurrent hypofractionated chemoradiotherapy and 3-weekly platinum doublet chemotherapy

Excessive esophageal toxicity in patients with locally advanced non-small cell lung cancer treated with concurrent hypofractionated chemoradiotherapy and 3-weekly platinum doublet chemotherapy

Introduction: Concurrent chemoradiation followed by immunotherapy is the standard of care for patients with stage III non-small cell lung cancer (NSCLC). Prior to the introduction of adjuvant immunotherapy, we treated patients with stage III NSCLC with concurrent platinum doublet chemotherapy and 66...

Full description

Bibliographic Details
Main Authors: Noëlle van der Voort van Zyp, Masoma Hashimzadah, Erik Kouwenhoven, Carmen Liskamp, Christa Gadellaa-van Hooijdonk, Ellen Pouw, Jose Belderbos, Klaartje Maas, Paul van de Vaart, Mirjam Mast
Format: Article
Language:English
Published: Elsevier 2022-09-01
Series:Clinical and Translational Radiation Oncology
Subjects:
Non-small cell lung cancer (NSCLC)
Concurrent chemoradiation
Hypofractionation
Platinum doublet chemotherapy
Esophageal toxicity
Online Access:http://www.sciencedirect.com/science/article/pii/S2405630822000556

Internet

http://www.sciencedirect.com/science/article/pii/S2405630822000556

Similar Items